All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
In antibody–drug conjugates, an anticancer drug, such as a radioactive compound or a cytotoxic drug, is bound to an antibody that specifically targets a certain protein found on tumor cells. This mechanism allows for enhanced killing of target cells. Inotuzumab ozogamicin is an example of a CD33-targeting antibody conjugated with a cytotoxic agent.